BridgeBio Pharma, Inc. (BBIO)
74.91
+4.18
(+5.91%)
USD |
NASDAQ |
Oct 30, 16:00
74.74
-0.17
(-0.23%)
After-Hours: 18:47
BridgeBio Pharma Cash and Short Term Investments (Annual) : 588.03M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 588.03M |
| December 31, 2024 | 681.23M |
| December 31, 2023 | 451.54M |
| December 31, 2022 | 509.85M |
| December 31, 2021 | 836.84M |
| Date | Value |
|---|---|
| December 31, 2020 | 607.09M |
| December 31, 2019 | 545.99M |
| December 31, 2018 | 436.09M |
| December 31, 2017 | 92.00M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Pfizer Inc. | 13.60B |
| Ionis Pharmaceuticals, Inc. | 2.677B |
| Cytokinetics, Inc. | 885.34M |
| Vertex Pharmaceuticals, Inc. | 6.611B |